Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024


PITTSBURGH, April 16, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.

Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.  Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).

Viatris OUS Logo (PRNewsfoto/Viatris Inc.)

 

SOURCE Viatris Inc.


These press releases may also interest you

at 17:55
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
Sinovac Biotech Ltd. ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The...

at 17:54
Meddux appoints Ben Trombold as new VP of Sales & Marketing
Meddux is thrilled to announce the appointment of Ben Trombold as the new Vice President of Sales & Marketing. With over 14 years of dedicated experience in the sales and marketing sector, Trombold brings a wealth of expertise and a proven track...

at 17:31
Malignant Ascites Market to Observe Growth at a CAGR of 1.2% by 2034 | DelveInsight
DelveInsight's Malignant Ascites Market Insights report includes a comprehensive understanding of current treatment practices, malignant ascites emerging...

at 17:26
Amped Fitness® Debuts All-New Luxury Signature Location in West Palm Beach, FL
Amped Fitness® has recently unveiled their highly anticipated luxury fitness oasis in the heart of West Palm Beach, FL. With fitness centers already booming throughout the South Florida area, Amped Fitness® is thrilled to announce their first ever...

at 17:18
SHATTERPROOF AND ANTHEM BLUE CROSS FOUNDATION PARTNER TO REDUCE HEALTHCARE STIGMA AROUND A SUBSTANCE USE DISORDER IN CALIFORNIA
A substance use disorder (SUD) is a complex and often stigmatized health condition that affects countless individuals, families and communities. Stigma against people with a SUD extends beyond individual and interpersonal levels. The Shatterproof...

at 17:15
AANA Presents U.S. Representative Jen Kiggans With National Health Leadership Award
(AANA) ? The American Association of Nurse Anesthesiology (AANA) recognized U.S. Representative Jen Kiggans (R-VA) as the winner of its National Health Leadership Award for 2024 at its Mid-Year Assembly, April 20-24, in Washington, DC....

More news about Health...


News published on and distributed by: